RESPONSE OF HUMAN FIBROBLASTS TO HYPERTONIC STRESS - CELL SHRINKAGE IS COUNTERACTED BY AN ENHANCED ACTIVE-TRANSPORT OF NEUTRAL AMINO-ACIDS

Citation
V. Dallasta et al., RESPONSE OF HUMAN FIBROBLASTS TO HYPERTONIC STRESS - CELL SHRINKAGE IS COUNTERACTED BY AN ENHANCED ACTIVE-TRANSPORT OF NEUTRAL AMINO-ACIDS, The Journal of biological chemistry, 269(14), 1994, pp. 10485-10491
Citations number
18
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
269
Issue
14
Year of publication
1994
Pages
10485 - 10491
Database
ISI
SICI code
0021-9258(1994)269:14<10485:ROHFTH>2.0.ZU;2-6
Abstract
Regulatory volume increase (RVI) has been studied in cultured human fi broblasts (CHF) incubated in a complete hypertonic growth medium (400 mosmol/kg). After the initial cell shrinkage induced by hypertonic tre atment, cells recover their volume almost completely within 3 h. This RVI response is associated with a marked increase of the cell content of free amino acids. The cell content of potassium increases only slig htly. Chromatographic analysis of the intracellular amino acid pool sh ows that the RVI-associated increase in cell amino acids is mainly a r esult of changes in the L-glutamine content. The intracellular accumul ation of the analog 2-methylaminoisobutyric acid, a specific substrate of transport system A, is increased in CHF undergoing RVI. Hypertonic treatment causes an immediate and sustained cell hyperpolarization, a s demonstrated by changes in the trans-membrane distribution ratio of L-arginine and in the fluorescence of the potential-sensitive dye bis- 1,3,-diethylthiobarbiturate-trimethineoxonol. Because of cell hyperpol arization, at the end of RVI the trans-membrane gradient of the sodium electrochemical potential is higher than that of the control. The inc rease in the extracellular potassium concentration ([K+](out) = 40 mM) abolishes the hyperpolarization induced by hypertonic treatment and d elays volume recovery. Cycloheximide suppresses RVI at a high but not at physiologic [K+](out). It is proposed that CHF counteract hypertoni c shrinkage through an enhanced accumulation of substrates of transpor t system A sustained, initially, by an increase in the energy availabl e for transport and, subsequently, also by the synthesis of new site A carriers.